RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
Large-scale real-world study by Bazarbach et al shows increased survival of relapsed Philadelphia positive acute #LymphoblasticLeukemia patients after allogeneic hematopoietic cell transplantation. https://t.co/DbwRBTC7tm @JindraPavel @ImanAboudalle https:
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
RT @TalhaBadarMD: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Po…
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation https://t.co/4HMqsjyEDL 2 yrs post alloHCT relapse improve from 27.8% to 54%. #leusm @
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation https://t.co/lUgLgV5Hr4
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation https://t.co/XaaaOupdgV
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
RT @Mohty_EBMT: 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post…
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation - A superb publication by the Acute Leukemia Working party of @TheEBMT @AnnaSureda5 h
RT @chr_reinhardt: Encouraging data, congrats A. Bazarbachi and @Mohty_EBMT. 20-Year Steady Increase in Survival of Adult Patients with Rel…
Encouraging data, congrats A. Bazarbachi and @Mohty_EBMT. 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation https://t.co/33uA0NpRvM
T: 👉Allojenik hematopoietik kök hücre nakli sonrası hastalığı nüks eden akut lenfoblastik #lösemi hastaları (Ph+) için, iki yıllık genel sağkalım oranı 2000-2004 döneminden 2015-2019 dönemine neredeyse iki katına çıkmıştır. https://t.co/SiHR2EEmrR
👉For acute lymphoblastic leukemia patients (Ph+) whose disease relapsed after allogeneic hematopoietic stem cell transplantation, the two-year overall survival rate has nearly doubled from the period between 2000-2004 to the period between 2015-2019. https